Gabapentin
Back to searchMolecule Structure
Scientific Name
Gabapentin
Description of the Drug
Gabapentin is an anticonvulsant medication used in the management of peripheral neuropathic pains, postherpetic neuralgia, and partial-onset seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00996
http://www.drugbank.ca/drugs/DB00996
Brand Name(s)
Gabapentin, Gralise, Neurontin
Company Owner(s)
Alkem Laboratories Ltd, Viatris Specialty Llc, Sun Pharmaceutical Industries Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Zydus Pharmaceuticals Usa Inc, Akorn Operating Co Llc, Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Voltage-gated calcium channel | PROTEIN COMPLEX GROUP | MODULATOR | CHEMBL2363032 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL8343 | ||
| PharmGKB | PA449720 | ||
| Human Metabolome Database | HMDB0005015 | ||
| DrugBank | DB00996 | ||
| PubChem: Thomson Pharma | 15171186 | ||
| PubChem | 6919078 | 3446 | |
| Mcule | MCULE-5392848565 | ||
| LINCS | LSM-5716 | ||
| Nikkaji | J39.388F | ||
| PDBe | GBN | ||
| BindingDB | 50080153 | ||
| EPA CompTox Dashboard | DTXSID0020074 | ||
| DrugCentral | 1264 | ||
| Brenda | 9643 | ||
| ChemicalBook | CB03374713 | CB3263316 | |
| Guide to Pharmacology | 5483 | ||
| rxnorm | NEURONTIN | GRALISE | GABAPENTIN |
| PubChem: Drugs of the Future | 12012796 | ||
| ChEBI | 42797 | ||
| ZINC | ZINC000000004949 |
